LETTERS TO THE EDITOR   

Panminerva Medica 2018 December;60(4):230-1

DOI: 10.23736/S0031-0808.18.03459-6

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Targeting microRNAs using nanotechnology in pulmonary diseases

Kamal DUA ^{1, 2, 3} ✉, Dinesh K. CHELLAPPAN ⁴, Gautam SINGHVI ⁵, Terezinha de JESUS ANDREOLI PINTO ⁶, Gaurav GUPTA ⁷, Philip M. HANSBRO ^{1, 2, 3}

¹ Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia; ² School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, Australia; ³ The Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, Australia; ⁴ Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Malaysia; ⁵ Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, India; ⁶ Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; ⁷ School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, India